FY2024 EPS Estimates for Henry Schein Reduced by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Leerink Partnrs decreased their FY2024 earnings per share estimates for shares of Henry Schein in a report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $4.74 for the year, down from their previous forecast of $4.81. The consensus estimate for Henry Schein’s current full-year earnings is $4.78 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2024 earnings at $1.19 EPS, Q1 2025 earnings at $1.19 EPS, Q2 2025 earnings at $1.24 EPS, Q3 2025 earnings at $1.25 EPS, Q4 2025 earnings at $1.32 EPS, FY2025 earnings at $5.00 EPS, FY2026 earnings at $5.57 EPS and FY2027 earnings at $6.19 EPS.

Several other research analysts also recently weighed in on the company. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Barrington Research restated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI raised their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.30.

Henry Schein Stock Up 5.0 %

HSIC stock opened at $79.87 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $9.96 billion, a price-to-earnings ratio of 32.87, a PEG ratio of 2.04 and a beta of 0.89. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock has a fifty day moving average of $73.19 and a 200-day moving average of $71.27.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue was up .4% compared to the same quarter last year. During the same period last year, the firm posted $1.32 EPS.

Insider Activity at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.14% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Henry Schein

Hedge funds have recently added to or reduced their stakes in the stock. Cromwell Holdings LLC lifted its stake in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares during the last quarter. Studio Investment Management LLC raised its position in Henry Schein by 3.8% during the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after purchasing an additional 172 shares in the last quarter. Central Pacific Bank Trust Division raised its position in Henry Schein by 2.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after purchasing an additional 200 shares in the last quarter. Huntington National Bank raised its position in Henry Schein by 16.8% during the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after purchasing an additional 218 shares in the last quarter. Finally, Bridge Creek Capital Management LLC raised its position in Henry Schein by 0.7% during the 4th quarter. Bridge Creek Capital Management LLC now owns 38,763 shares of the company’s stock valued at $2,682,000 after purchasing an additional 260 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.